Translational analysis of esophageal adenocarcinoma (EAC) patients treated with oxaliplatin and capecitabine (Xelox) +/- the dual ErbB inhibitor AZD8931 in the DEBIOC study
- Publication date
- 1 January 2020
- Publisher
- 'American Society of Clinical Oncology (ASCO)'